Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06100185 · ClinicalTrials.gov registry record · NA
Wearable Transcranial Electrical Stimulation (tES) for Insomnia
A NA study of Insomnia, sponsored by Uniformed Services University of the Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06100185: Recruiting NA study of Insomnia, sponsored by Uniformed Services University of the Health Sciences.
NCT06100185 is a NA study of Insomnia that is actively recruiting participants, run by Uniformed Services University of the Health Sciences. The registered enrollment target is 100 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06100185, a NA study of Insomnia, is actively recruiting participants, sponsored by Uniformed Services University of the Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the ability of a translational device, Teledyne PeakSleep, to reduce sleep onset latency, reduce time awake after sleep onset and improve restfulness and the subjective benefits of sleep in a patient population with insomnia via transcranial direct current stimulation (tDCS) applied to frontal lobe circuits.
Primary Outcome
FitBit actigraphy data will be collected to measure daily sleep onset latency (SOL) for two weeks at baseline (weeks 1-2, averaged) and compared to that of the study period (weeks 3-5).
Conditions Studied
Interventions
- DEVICE Sham
- DEVICE PeakSleep
Study Locations (1)
Maryland
- Walter Reed National Military Medical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-25 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT06100185 shows while recruiting
NCT06100185 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT06100185 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06100185 about?
NCT06100185 is a clinical study titled "Wearable Transcranial Electrical Stimulation (tES) for Insomnia". The purpose of this study is to investigate the ability of a translational device, Teledyne PeakSleep, to reduce sleep onset latency, reduce time awake after sleep onset and improve restfulness and the subjective benefits of sleep in a patient population with insomnia via transcranial direct current...
What is the current status of trial NCT06100185?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-25. Estimated completion is 2026-01.
What conditions does trial NCT06100185 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT06100185?
The interventions under investigation include: Sham (DEVICE), PeakSleep (DEVICE).
Who is sponsoring clinical trial NCT06100185?
This trial is sponsored by Uniformed Services University of the Health Sciences, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06100185 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06100185's enrollment target sits among peer trials
100 61st of 151 higher than 85 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI